Monroe D. Dowling

2.1k total citations
25 papers, 1.6k citations indexed

About

Monroe D. Dowling is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Hematology. According to data from OpenAlex, Monroe D. Dowling has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Genetics and 7 papers in Hematology. Recurrent topics in Monroe D. Dowling's work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Monroe D. Dowling is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Monroe D. Dowling collaborates with scholars based in United States, India and Ireland. Monroe D. Dowling's co-authors include Toby Gee, Bayard D. Clarkson, Joseph H. Burchenal, Isabel Cunningham, Sidney Cobb, John R. Caldwell, Scot Sorensen, D F Moravec, Mark Hutchins and David Howe and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Monroe D. Dowling

24 papers receiving 1.4k citations

Peers

Countries citing papers authored by Monroe D. Dowling

Since Specialization

Citations

This map shows the geographic impact of Monroe D. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monroe D. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monroe D. Dowling more than expected).

Fields of papers citing papers by Monroe D. Dowling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monroe D. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monroe D. Dowling. The network helps show where Monroe D. Dowling may publish in the future.

Co-authorship network of co-authors of Monroe D. Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of Monroe D. Dowling. A scholar is included among the top collaborators of Monroe D. Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monroe D. Dowling. Monroe D. Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of Acute Myeloblastic Leukemia1 2015 ·Proceedings of the International Symposium on Comparative Leukemia Research ·B Clarkson, Monroe D. Dowling, Toby Gee, Joseph H. Burchenal	0
2	Review of environmental morphine identifications: worldwide occurrences and responses of authorities. 2005 ·UKnowledge (University of Kentucky) ·(unknown), Andreas F. Lehner, (unknown), (unknown), Pierce V. Kavanagh, Noel A. Brennan, Monroe D. Dowling, Thomas Tobin	5
3	CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity. 1991 ·Journal of Clinical Oncology ·Julie M. Vose, P. J. Bierman, J R Anderson, Dennis D. Weisenburger, D F Moravec, Scot Sorensen, Mark Hutchins, Monroe D. Dowling, David Howe, (unknown)	20
4	Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation 1989 ·The American Journal of Medicine ·(unknown), Jamés O. Armitage, Philip J. Bierman, Dennis D. Weisenburger, Mark Hutchins, Monroe D. Dowling, D F Moravec, Scot Sorensen, (unknown), G.K. Bascom, David Howe, Patrick S. Johnson, Robert M. Langdon, James A. Mailliard, (unknown), (unknown), Anne Kessinger	44
5	Ch1VPP—An Effective and Well-Tolerated Alternative to MOPP Therapy for Hodgkinʼs Disease 1988 ·American Journal of Clinical Oncology ·Julie M. Vose, (unknown), DD Weisenburger, D F Moravec, Mark Hutchins, David Howe, Scot Sorensen, Monroe D. Dowling, (unknown), (unknown), (unknown), R. J. Thompson	14
6	The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. 1988 ·Journal of Clinical Oncology ·Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger, Philip J. Bierman, Scot Sorensen, Mark Hutchins, D F Moravec, David Howe, Monroe D. Dowling, J A Mailliard	225
7	Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions. 1986 ·Journal of Clinical Oncology ·Jamés O. Armitage, DD Weisenburger, Mark Hutchins, D F Moravec, Monroe D. Dowling, Scot Sorensen, J A Mailliard, (unknown), Patrick S. Johnson, David Howe	132
8	Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. 1983 ·Journal of Clinical Oncology ·Peter Schauer, Z Arlin, Roland Mertelsmann, Constance Cirrincione, (unknown), Toby Gee, Monroe D. Dowling, Sanford Kempin, David J. Straus, Benjamín Koziner	124
9	Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). 1982 ·Blood ·Sanford Kempin, (unknown), Howard T. Thaler, Benjamín Koziner, (unknown), Toby Gee, Z Arlin, C. Little, David J. Straus, Lillian Reich, Elizabeth H. Phillips, Hamid Al‐Mondhiry, Monroe D. Dowling, Kenneth H. Mayer, B Clarkson	79
10	Treatment of acute nonlymphocytic leukemia in adults: Response to 2,2-anhydro-1-B-D-Arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol 1981 ·Cancer ·Roland Mertelsmann, (unknown), Toby Gee, Sanford Kempin, Sharon Passe, Howard T. Thaler, Zalmen A. Arlin, Monroe D. Dowling, (unknown), Susan McKenzie, (unknown), (unknown), Herbert F. Oettgen, Joseph H. Burchenal, Bayard D. Clarkson	10
11	Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol) 1979 ·Blood ·(unknown), (unknown), Monroe D. Dowling, RS Chaganti, (unknown), (unknown), (unknown), Alan D. Turnbull, (unknown), (unknown)	154
12	Rosette formation of human null lymphocytes with Rhesus monkey erythrocytes. 1978 ·PubMed ·Jen Wei Chiao, Monroe D. Dowling, R A Good	5
13	Prophylactic heparin therapy in acute promyelocytic leukemia 1978 ·Cancer ·(unknown), Toby Gee, Monroe D. Dowling, Zalmen A. Arlin, Susan McKenzie, Sanford Kempin, Bayard D. Clarkson	113
14	Relationship of a T-Lymphocyte marker to phase of cell cycle and morphology of leukemic cells 1977 ·Cancer ·Zalmen A. Arlin, Jen Wei Chiao, Jerrold Fried, Monroe D. Dowling, Bayard D. Clarkson, Robert A. Good	4
15	Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside. 1976 ·PubMed ·Joseph H. Burchenal, (unknown), Kathleen Kalaher, Tara O’Toole, (unknown), Monroe D. Dowling, (unknown), K. A. WATANABE, Iris Wempen, Jack J. Fox	58
16	Treatment of acute leukemia in adults 1975 ·Cancer ·Bayard D. Clarkson, Monroe D. Dowling, Toby Gee, Isabel Cunningham, Joseph H. Burchenal	177
17	Studies of cellular proliferation in human leukemiaVIII. The generation time and growth fraction in lymphosarcoma in a leukemic phase during advanced and early relapsing disease 1975 ·Cancer ·(unknown), Jerrold Fried, Monroe D. Dowling, Bayard D. Clarkson	10
18	Perianal and anorectal complications in leukemia 1973 ·Cancer ·(unknown), Monroe D. Dowling, (unknown), Maus W. Stearns	40
19	Oral and parenteral activity of 2,2'-anhydro-1- -D-arabinofuranosyl-5-fluorocytosine against both intraperitoneally and intracerebrally inoculated mouse leukemia. 1972 ·PubMed ·James J. Fox, Elvira A. Falco, Iris Wempen, (unknown), Monroe D. Dowling, Joseph H. Burchenal	18
20	Treatment of Acute Lymphoblastic Leukemia 1972 ·Annual Review of Medicine ·Joseph H. Burchenal, Monroe D. Dowling, Charlotte Tan	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact